- Home
- XLO vs TURN Comparison
XLO vs TURN Comparison
Compare XLO & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- TURN
- Stock Information
- Founded
- XLO 2016
- TURN 1981
- Country
- XLO United States
- TURN United States
- Employees
- XLO N/A
- TURN N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- XLO Health Care
- TURN Finance
- Exchange
- XLO Nasdaq
- TURN Nasdaq
- Market Cap
- XLO 42.1M
- TURN 35.4M
- IPO Year
- XLO 2021
- TURN N/A
- Fundamental
- Price
- XLO $1.11
- TURN $3.58
- Analyst Decision
- XLO Buy
- TURN
- Analyst Count
- XLO 1
- TURN 0
- Target Price
- XLO $4.00
- TURN N/A
- AVG Volume (30 Days)
- XLO 738.6K
- TURN 37.5K
- Earning Date
- XLO 11-07-2024
- TURN 02-18-2025
- Dividend Yield
- XLO N/A
- TURN N/A
- EPS Growth
- XLO N/A
- TURN N/A
- EPS
- XLO N/A
- TURN N/A
- Revenue
- XLO $4,620,000.00
- TURN $129,297.00
- Revenue This Year
- XLO N/A
- TURN N/A
- Revenue Next Year
- XLO $368.76
- TURN N/A
- P/E Ratio
- XLO N/A
- TURN N/A
- Revenue Growth
- XLO N/A
- TURN 6.32
- 52 Week Low
- XLO $0.50
- TURN $3.12
- 52 Week High
- XLO $1.93
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- XLO 54.59
- TURN 50.59
- Support Level
- XLO $0.84
- TURN $3.47
- Resistance Level
- XLO $1.28
- TURN $3.80
- Average True Range (ATR)
- XLO 0.13
- TURN 0.12
- MACD
- XLO 0.01
- TURN -0.03
- Stochastic Oscillator
- XLO 62.72
- TURN 28.95
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.